Key Insights

Highlights

Success Rate

33% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

22.2%

2 terminated out of 9 trials

Success Rate

33.3%

-53.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

33% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (6)
P 2 (1)

Trial Status

Unknown2
Active Not Recruiting2
Terminated2
Completed1
Recruiting1
Not Yet Recruiting1

Trial Success Rate

33.3%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (9)

Research Network

Activity Timeline